Apple, known for its innovative tech, has hit a roadblock in the US with the recent cessation of sales for their latest Series 9 and Ultra 2 watch models. The abrupt halt in sales, as indicated on their website, has left many wondering about the cause behind this sudden disruption in the market.
The root of the problem lies in a patent dispute concerning the watch sensor responsible for measuring blood oxygen levels—a key feature of these watch models. Masimo, a prominent medical technology company specializing in products for hospitals, holds the patent that Apple’s sensor apparently violated.
This clash between the two tech giants has been ongoing for over three years, culminating in legal actions. Masimo filed cases with both the US District Court in California and the US International Trade Commission (ITC). The latter decision went against Apple, resulting in a ban on importing the Ultra 2 and Series 9 watches from Apple’s manufacturing base in China.
As a consequence, Apple’s website now explicitly mentions the discontinuation of Apple Watch units in the US that possess blood oxygen measurement capabilities. However, the Apple Watch SE remains available for purchase in the US market.
While retail giants like Walmart and Best Buy can continue selling their existing stock of the banned models, restocking these items won’t be an option once supplies dwindle.
The ban not only impacts sales but also complicates repairs for existing Apple Watches equipped with blood oxygen sensors. Apple has reportedly informed its staff via an internal memo that they will no longer replace out-of-warranty models starting from the Apple Watch Series 6—a move raising concerns among customers seeking repairs unrelated to the disputed blood oxygen sensor.
The duration of the ban remains uncertain, contingent upon Apple’s strategy to address the issue. Potential solutions include altering the watch’s software algorithm to comply with the patent or negotiating a settlement with Masimo, though the latter might not align with Apple’s ideal resolution.
Apple’s hope hinges on US Trade Representative Katherine Tai, who holds the power to veto the ban before the holiday season kicks in. The company faces a critical moment as its stock has already taken a hit, and the impact on watch sales during the busiest shopping season of the year is anticipated.
The situation is complex, involving legal battles, technology adjustments, and potential settlements. How Apple navigates this challenge will not only determine the fate of these watch models but also have lasting implications for the company’s standing in the market.
Leave a Reply